Domingo Caparas, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 500 W 4th St, Odessa, TX 79761 Phone: 432-640-2834 Fax: 432-640-2897 |
Sridhar Enuganti, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 500 W 4th St, Odessa, TX 79761 Phone: 432-640-4000 Fax: 432-640-3462 |
Fouzia Tabasam, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 500 W 4th St, Odessa, TX 79761 Phone: 432-640-4000 Fax: 432-640-3462 |
Anam Hassan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 W 5th St, Odessa, TX 79763 Phone: 432-703-5375 |
Sudhir Bare, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 500 W 4th St, Odessa, TX 79761 Phone: 432-640-2834 Fax: 432-640-2897 |
Elliana Regina Wiesner, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 500 W 4th St, Odessa, TX 79761 Phone: 432-640-4000 Fax: 432-640-4606 |
Ramcharitha Kandikatla, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 500 W 4th St, Odessa, TX 79761 Phone: 432-640-4000 Fax: 432-640-2897 |
News Archive
Itxaro Perez, a biochemist at the University of the Basque Country (UPV/EHU), has contributed in such a way that, in the long term, the early diagnosis of cancer of the large intestine could be feasible.
Jefferson Hospital for Neuroscience (JHN) is launching the Jefferson Neuroscience Network (JNN) to promote collaboration among area hospitals to advance neuroscience care throughout the region. Chestnut Hill Hospital is the first hospital to join JNN. Through this collaboration, Jefferson and Chestnut Hill will provide the most sophisticated care and expertise available to patients with time-sensitive neurovascular diseases.
PSI's "Global Health Impact" blog features a video interview by the Center for Strategic & International Studies (CSIS) in which "former UNAIDS Executive Director Peter Piot discusses with CSIS Senior Vice President and Director of the Global Health Policy Center J. Stephen Morrison the lessons he has learned in his years fighting AIDS."
Aphios Corporation has received a Phase II SBIR grant from the National Institutes of Health (NIH) amounting to $2.4 million over two years. The National Institute on Aging (NIA), part of the NIH, awarded the grant to the Aphios Corporation to develop an "Alzheimer's Disease Therapeutic."
› Verified 8 days ago